Sunshine Heart can resume trial after FDA OKs 'minor' changes – MassDevice

Sunshine Heart (NSDQ:SSH) said last week that the FDA will let it resume a clinical trial of its C-Pulse heart failure device once the safety watchdog approves "minor protocol changes."